{"&cites=6344570488949834669&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of …","url":"https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/2050-6511-14-1?optIn=true","authors":["S Dunne","S Dunne B Shannon","S Dunne B Shannon C Dunne…"],"year":2013,"numCitations":176,"pdf":"https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/2050-6511-14-1?optIn=true","citationUrl":"http://scholar.google.com/scholar?cites=5811917031498073616&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:EEZ8Tr8TqFAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5811917031498073616&hl=en&as_sdt=2005&sciodt=0,5","publication":"bmcpharmacoltoxicol.biomedcentral …","p":1,"exp":1596876810194},{"title":"What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs","url":"https://link.springer.com/article/10.1186/s12916-015-0415-3","authors":["SS Dunne","SS Dunne CP Dunne"],"year":2015,"numCitations":112,"pdf":"https://link.springer.com/article/10.1186/s12916-015-0415-3","citationUrl":"http://scholar.google.com/scholar?cites=1124525902072822870&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:VrzGlVkemw8J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1124525902072822870&hl=en&as_sdt=2005&sciodt=0,5","publication":"Springer"},{"title":"Personalizing health care: feasibility and future implications","url":"https://link.springer.com/article/10.1186/1741-7015-11-179","authors":["B Godman","B Godman AE Finlayson","B Godman AE Finlayson PK Cheema…"],"year":2013,"numCitations":95,"pdf":"https://link.springer.com/article/10.1186/1741-7015-11-179","citationUrl":"http://scholar.google.com/scholar?cites=13838316196388620654&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:bklHF0OTC8AJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13838316196388620654&hl=en&as_sdt=2005&sciodt=0,5","publication":"Springer"},{"title":"Discounts and rebates granted to public payers for medicines in European countries","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471187/","authors":["S Vogler","S Vogler N Zimmermann","S Vogler N Zimmermann C Habl…"],"year":2012,"numCitations":89,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471187/","citationUrl":"http://scholar.google.com/scholar?cites=3121680952657032052&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:dLM5fUlwUisJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3121680952657032052&hl=en&as_sdt=2005&sciodt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs","url":"https://www.frontiersin.org/articles/10.3389/fphar.2013.00039/full","authors":["R Malmstrom","R Malmstrom B Godman","R Malmstrom B Godman E Diogene…"],"year":2013,"numCitations":88,"pdf":"https://www.frontiersin.org/articles/10.3389/fphar.2013.00039/full","citationUrl":"http://scholar.google.com/scholar?cites=4795503353889609289&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:SdbIh-QMjUIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4795503353889609289&hl=en&as_sdt=2005&sciodt=0,5","publication":"frontiersin.org"},{"title":"Demand-side policies to encourage the use of generic medicines: an overview","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.12.83","authors":["P Dylst","P Dylst A Vulto","P Dylst A Vulto S Simoens"],"year":2013,"numCitations":85,"pdf":"https://www.researchgate.net/profile/Pieter_Dylst/publication/235602724_Demand-side_policies_to_encourage_the_use_of_generic_medicines_An_overview/links/0c960521dc92ad8b87000000.pdf","citationUrl":"http://scholar.google.com/scholar?cites=2768965520802723136&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:QDXAdnhXbSYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2768965520802723136&hl=en&as_sdt=2005&sciodt=0,5","publication":"Taylor & Francis"},{"title":"Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries","url":"https://www.tandfonline.com/doi/abs/10.1586/14737167.2013.820956","authors":["B Godman","B Godman I Bishop","B Godman I Bishop AE Finlayson…"],"year":2013,"numCitations":80,"pdf":"http://www.academia.edu/download/42150090/Reforms_and_initiatives_in_Scotland_in_r20160205-30232-pbgllg.pdf","citationUrl":"http://scholar.google.com/scholar?cites=10743432046301021574&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:hgVSZIZWGJUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10743432046301021574&hl=en&as_sdt=2005&sciodt=0,5","publication":"Taylor & Francis"},{"title":"A review of generic medicine pricing in Europe","url":"http://www.stsimonpharmacy.com/docs/PH3340%20201314/GaBIJ-2012-1-p8-12-ReviewArticle-Simoens.pdf","authors":["S Simoens"],"year":2012,"numCitations":78,"pdf":"http://www.stsimonpharmacy.com/docs/PH3340%20201314/GaBIJ-2012-1-p8-12-ReviewArticle-Simoens.pdf","citationUrl":"http://scholar.google.com/scholar?cites=13396001645361108531&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:MxZMeoUo6LkJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13396001645361108531&hl=en&as_sdt=2005&sciodt=0,5","publication":"stsimonpharmacy.com"},{"title":"Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach","url":"http://gabi-journal.net/payers-endorse-generics-to-enhance-prescribing-efficiency-impact-and-future-implications-a-case-history-approach.html","authors":["B Godman","B Godman M Abuelkhair","B Godman M Abuelkhair A Vitry","B Godman M Abuelkhair A Vitry S Abdu","B Godman M Abuelkhair A Vitry S Abdu M Bennie…"],"year":2012,"numCitations":67,"pdf":"http://gabi-journal.net/payers-endorse-generics-to-enhance-prescribing-efficiency-impact-and-future-implications-a-case-history-approach.html","citationUrl":"http://scholar.google.com/scholar?cites=2469362426686362994&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:clVWOAvwRCIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2469362426686362994&hl=en&as_sdt=2005&sciodt=0,5","publication":"gabi-journal.net"},{"title":"Reference pricing systems in Europe: characteristics and consequences","url":"http://gabi-journal.net/reference-pricing-systems-in-europe-characteristics-and-consequences.html","authors":["P Dylst","P Dylst A Vulto","P Dylst A Vulto S Simoens"],"year":2012,"numCitations":64,"pdf":"http://gabi-journal.net/reference-pricing-systems-in-europe-characteristics-and-consequences.html","citationUrl":"http://scholar.google.com/scholar?cites=10550691210464655468&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:bPiUhsGVa5IJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10550691210464655468&hl=en&as_sdt=2005&sciodt=0,5","publication":"gabi-journal.net"}]}